- Home
- BNR vs FLUX Comparison
BNR vs FLUX Comparison
Compare BNR & FLUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNR
- FLUX
- Stock Information
- Founded
- BNR 2014
- FLUX N/A
- Country
- BNR China
- FLUX United States
- Employees
- BNR N/A
- FLUX N/A
- Industry
- BNR Medical Specialities
- FLUX Industrial Machinery/Components
- Sector
- BNR Health Care
- FLUX Miscellaneous
- Exchange
- BNR Nasdaq
- FLUX Nasdaq
- Market Cap
- BNR 29.1M
- FLUX 26.9M
- IPO Year
- BNR 2020
- FLUX N/A
- Fundamental
- Price
- BNR $3.56
- FLUX $2.38
- Analyst Decision
- BNR
- FLUX Strong Buy
- Analyst Count
- BNR 0
- FLUX 2
- Target Price
- BNR N/A
- FLUX $6.00
- AVG Volume (30 Days)
- BNR 36.5K
- FLUX 106.6K
- Earning Date
- BNR 08-21-2025
- FLUX 08-15-2025
- Dividend Yield
- BNR N/A
- FLUX N/A
- EPS Growth
- BNR N/A
- FLUX N/A
- EPS
- BNR N/A
- FLUX N/A
- Revenue
- BNR $72,112,038.00
- FLUX $63,074,000.00
- Revenue This Year
- BNR $136.32
- FLUX $11.10
- Revenue Next Year
- BNR N/A
- FLUX $12.66
- P/E Ratio
- BNR N/A
- FLUX N/A
- Revenue Growth
- BNR 0.53
- FLUX N/A
- 52 Week Low
- BNR $2.18
- FLUX $1.15
- 52 Week High
- BNR $7.90
- FLUX $4.75
- Technical
- Relative Strength Index (RSI)
- BNR 56.51
- FLUX 81.25
- Support Level
- BNR $3.06
- FLUX $1.36
- Resistance Level
- BNR $3.50
- FLUX $1.60
- Average True Range (ATR)
- BNR 0.27
- FLUX 0.17
- MACD
- BNR -0.01
- FLUX 0.09
- Stochastic Oscillator
- BNR 54.35
- FLUX 87.18
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
About FLUX Flux Power Holdings Inc.
Flux Power Holdings Inc design, develop, manufacture, and sell a portfolio of lithium-ion energy storage solutions for electrification of a range of industrial commercial sectors which include material handling, airport ground support equipment (GSE), and other commercial and industrial applications. It offers a high-power battery cell management system(BMS). The company's BMS provides three functions to its battery systems which include Cell Balancing, Monitoring, and Error Reporting.